Threoninyl-Isoleucine

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: Threoninyl-Isoleucine
• 英文别名: 2-[(2-amino-3-hydroxybutanoyl)amino]-3-methylpentanoic acid
• 化学式: C₁₀H₂₀N₂O₄
• 分子量: 232.28
• InChiKey: LUMXICQAOKVQOB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.7
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  113
• 氢给体数：
  4
• 氢受体数：
  5

文献信息

• METHODS OF DIAGNOSING DISEASE
  申请人：4D Pharma Cork Limited

  公开号：EP3947743A1

  公开（公告）日：2022-02-09
• SYSTEMS AND METHODS FOR PROFILING AND CLASSIFYING HEALTH-RELATED FEATURES
  申请人：The Regents of the University of California

  公开号：US20200194126A1

  公开（公告）日：2020-06-18

  Embodiments of the present systems and methods may provide techniques that may profile and quantify the microbiome and metabolome and identify the novel health, lifestyle, and environmental-related proteins that they affect. Embodiments may provide the capability for the classification of patients or other biological entities into clinical or non-clinical but related groups and labels, based on assessment of their microbiome and metabolome. Embodiments may provide the capability to assess patient health, identify disease risk factors, identify, and rank therapeutic targets, determine the functional contributions of the microbiome to patient health, and even predict outcomes such as disease development and drug response. Other embodiments may provide consumers with lifestyle related information and comparisons with other consumers' data, potentially allowing consumers to tailor lifestyle choices such as nutrition, exercise, and supplementation. Furthermore, other embodiments may provide health assessments that pertain to animal or environmental related entities.
• [EN] METHODS OF DIAGNOSING DISEASE<br/>[FR] PROCÉDÉS DE DIAGNOSTIC D'UNE MALADIE
  申请人：4D PHARMA CORK LTD

  公开号：WO2020201457A1

  公开（公告）日：2020-10-08

  The application provides new and improved methods for diagnosing IBS.